Source: Annual Congress 2005 - Airway biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. M. Stankovic, A. I. Divac, A. M. Nikolic, M. M. Mitic-Milikic, L. M. Nagorni-Obradovic, N. D. Petrovic-Stanojevic, V. B. Dopudja-Pantic, M. M. Surlan, I. R. Vujicic, D. R. Ponomarov, D. P. Radojkovic (Belgrade, Serbia And Montenegro). High frequency of CFTR R75Q variant and mEPHX „slow" allele in COPD patients. Eur Respir J 2005; 26: Suppl. 49, 2240

Member's Comments

No comment yet.

Related content which might interest you: Therapeutic response in COPD patients with CFTR R75Q variant and mEPHX "slow" allele – is there a difference? Source: Eur Respir J 2006; 28: Suppl. 50, 30s Year: 2006 Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C Source: Eur Respir J 2001; 17: 1195-1200 Year: 2001 Association of C3435T polymorphism of MDR1 gene and T1808A polymorphism of NR3C1 gene with bronchial obstruction in severe asthmatics and COPD patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Evaluation of glycine allele frequency in patients with mild asthma Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 M2 allele of alpha1-antitrypsin gene and genetic susceptibility to COPD in Korean men Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 Heterozygous genotype rs17580 AT (PiS) in SERPINA1 is associated to COPD secondary to biomass and tobacco smoke. Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 The allelic frequency for S and Z mutations in the SERPINA1 gene in NSCLC patients from Poland Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 GSTT1 null alleles are risk factors for excess FEV1 decline in the general population, but GSTM1 null alleles only in smokers Source: Eur Respir J 2007; 30: Suppl. 51, 447s Year: 2007 Assessment of asthma control in asthmatic patients Brazilian carriers of the Arg16Gly polymorphism of the β2 adrenorreceptor gene Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype Source: Eur Respir J 2005; 25: 468-473 Year: 2005 Airway inflammation in CF patients with a 1237A polymorphism in the Alpha-1PI gene Source: Eur Respir J 2001; 18: Suppl. 33, 1s Year: 2001 Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies Year: 2003 Variable phenotype associated with SP-C gene mutations: fatal case with the I73T mutation Source: Eur Respir J 2004; 24: 1072-1073 Year: 2004 CARD15/NOD2 3020insC (1007fs) mutation is not a genetic marker for cytokine network in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 520s Year: 2006 Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis patients with the CFTR I1234V mutation in a large kindred family Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 Carriers of a single CFTR mutation are asymptomatic: an evolving dogma? Source: Eur Respir J, 56 (3) 2002645; 10.1183/13993003.02645-2020 Year: 2020 Frequency of snp Arg16Gly of the b2-ar gene in Brazilian asthmatics patients Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Influence of allele variants of CYP2A6 and NAT2 genes on features of phenotype of tobacco smoker Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004 Phenotype and outcome of PAH patients carrying a TBX4 mutation Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020